586 related articles for article (PubMed ID: 28923377)
1. Clinical and analytical evaluation of the new Aptima Mycoplasma genitalium assay, with data on M. genitalium prevalence and antimicrobial resistance in M. genitalium in Denmark, Norway and Sweden in 2016.
Unemo M; Salado-Rasmussen K; Hansen M; Olsen AO; Falk M; Golparian D; Aasterød M; Ringlander J; Nilsson CS; Sundqvist M; Schønning K; Moi H; Westh H; Jensen JS
Clin Microbiol Infect; 2018 May; 24(5):533-539. PubMed ID: 28923377
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of Mycoplasma genitalium and Antibiotic Resistance-Associated Mutations in Patients at a Sexually Transmitted Infection Clinic in Iceland, and Comparison of the S-DiaMGTV and Aptima Mycoplasma genitalium Assays for Diagnosis.
Hilmarsdóttir I; Arnardóttir EM; Jóhannesdóttir ER; Valsdóttir F; Golparian D; Hadad R; Vigfússon HB; Unemo M
J Clin Microbiol; 2020 Aug; 58(9):. PubMed ID: 32611793
[No Abstract] [Full Text] [Related]
3. Clinical Importance of Superior Sensitivity of the Aptima TMA-Based Assays for Mycoplasma genitalium Detection.
Salado-Rasmussen K; Tolstrup J; Sedeh FB; Larsen HK; Unemo M; Jensen JS
J Clin Microbiol; 2022 Apr; 60(4):e0236921. PubMed ID: 35317613
[TBL] [Abstract][Full Text] [Related]
4. French Prospective Clinical Evaluation of the Aptima Mycoplasma genitalium CE-IVD Assay and Macrolide Resistance Detection Using Three Distinct Assays.
Le Roy C; Pereyre S; Hénin N; Bébéar C
J Clin Microbiol; 2017 Nov; 55(11):3194-3200. PubMed ID: 28794183
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of Mycoplasma genitalium and mutations associated with macrolide and fluoroquinolone resistance in Finland.
Hokynar K; Hiltunen-Back E; Mannonen L; Puolakkainen M
Int J STD AIDS; 2018 Aug; 29(9):904-907. PubMed ID: 29631509
[TBL] [Abstract][Full Text] [Related]
6. Impact of mass drug administration of azithromycin for trachoma elimination on prevalence and azithromycin resistance of genital
Harrison MA; Harding-Esch EM; Marks M; Pond MJ; Butcher R; Solomon AW; Zhou L; Tan N; Nori AV; Kako H; Sokana O; Mabey DCW; Sadiq ST
Sex Transm Infect; 2019 Nov; 95(7):522-528. PubMed ID: 30981999
[TBL] [Abstract][Full Text] [Related]
7. High Prevalence of Macrolide and Fluoroquinolone Resistance-Mediating Mutations in Mycoplasma genitalium-Positive Urine Specimens From Saskatchewan.
Parmar NR; Mushanski L; Wanlin T; Lepe A; Lang A; Minion J; Dillon JR
Sex Transm Dis; 2021 Sep; 48(9):680-684. PubMed ID: 34397971
[TBL] [Abstract][Full Text] [Related]
8. Prospective Evaluation of ResistancePlus MG, a New Multiplex Quantitative PCR Assay for Detection of Mycoplasma genitalium and Macrolide Resistance.
Tabrizi SN; Su J; Bradshaw CS; Fairley CK; Walker S; Tan LY; Mokany E; Garland SM
J Clin Microbiol; 2017 Jun; 55(6):1915-1919. PubMed ID: 28381611
[No Abstract] [Full Text] [Related]
9. Evaluation of the new AmpliSens multiplex real-time PCR assay for simultaneous detection of Neisseria gonorrhoeae, Chlamydia trachomatis, Mycoplasma genitalium, and Trichomonas vaginalis.
Rumyantseva T; Golparian D; Nilsson CS; Johansson E; Falk M; Fredlund H; Van Dam A; Guschin A; Unemo M
APMIS; 2015 Oct; 123(10):879-86. PubMed ID: 26299582
[TBL] [Abstract][Full Text] [Related]
10. Treatment efficacy, treatment failures and selection of macrolide resistance in patients with high load of Mycoplasma genitalium during treatment of male urethritis with josamycin.
Guschin A; Ryzhikh P; Rumyantseva T; Gomberg M; Unemo M
BMC Infect Dis; 2015 Feb; 15():40. PubMed ID: 25645440
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of mutations associated with resistance to macrolides and fluoroquinolones in Mycoplasma genitalium: a systematic review and meta-analysis.
Machalek DA; Tao Y; Shilling H; Jensen JS; Unemo M; Murray G; Chow EPF; Low N; Garland SM; Vodstrcil LA; Fairley CK; Hocking JS; Zhang L; Bradshaw CS
Lancet Infect Dis; 2020 Nov; 20(11):1302-1314. PubMed ID: 32622378
[TBL] [Abstract][Full Text] [Related]
12.
Björnelius E; Magnusson C; Jensen JS
Sex Transm Infect; 2017 May; 93(3):167-168. PubMed ID: 27502694
[TBL] [Abstract][Full Text] [Related]
13. Molecular epidemiological analysis of
Laumen JGE; van Alphen LB; Maduna LD; Hoffman CM; Klausner JD; Medina-Marino A; Kock MM; Peters RPH
Sex Transm Infect; 2021 Mar; 97(2):152-156. PubMed ID: 32389900
[TBL] [Abstract][Full Text] [Related]
14. Detection of macrolide resistance in Mycoplasma genitalium in France.
Chrisment D; Charron A; Cazanave C; Pereyre S; Bébéar C
J Antimicrob Chemother; 2012 Nov; 67(11):2598-601. PubMed ID: 22773740
[TBL] [Abstract][Full Text] [Related]
15. Mutations in ParC and GyrA of moxifloxacin-resistant and susceptible Mycoplasma genitalium strains.
Hamasuna R; Le PT; Kutsuna S; Furubayashi K; Matsumoto M; Ohmagari N; Fujimoto N; Matsumoto T; Jensen JS
PLoS One; 2018; 13(6):e0198355. PubMed ID: 29883482
[TBL] [Abstract][Full Text] [Related]
16. Time to eradication of Mycoplasma genitalium after antibiotic treatment in men and women.
Falk L; Enger M; Jensen JS
J Antimicrob Chemother; 2015 Nov; 70(11):3134-40. PubMed ID: 26283670
[TBL] [Abstract][Full Text] [Related]
17. Mycoplasma genitalium prevalence and macrolide resistance-associated mutations and coinfection with Chlamydia trachomatis in Southern Jutland, Denmark.
Desdorf R; Andersen NM; Chen M
APMIS; 2021 Dec; 129(12):706-710. PubMed ID: 34580906
[TBL] [Abstract][Full Text] [Related]
18. High levels of macrolide resistance-associated mutations in Mycoplasma genitalium warrant antibiotic susceptibility-guided treatment.
Nijhuis RH; Severs TT; Van der Vegt DS; Van Zwet AA; Kusters JG
J Antimicrob Chemother; 2015 Sep; 70(9):2515-8. PubMed ID: 25995292
[TBL] [Abstract][Full Text] [Related]
19. Sensitive and specific assay for the simultaneous detection of Mycoplasma genitalium and macrolide resistance-associated mutations.
Braam JF; van Marm S; Severs TT; Belousov Y; Mahoney W; Kusters JG
Eur J Clin Microbiol Infect Dis; 2018 Nov; 37(11):2137-2144. PubMed ID: 30276584
[TBL] [Abstract][Full Text] [Related]
20. Prevalence and antibiotic resistance of
Gratrix J; Plitt S; Turnbull L; Smyczek P; Brandley J; Scarrott R; Naidu P; Parker P; Blore B; Bull A; Shokoples S; Bertholet L; Martin I; Chernesky M; Read R; Singh A
BMJ Open; 2017 Jul; 7(7):e016300. PubMed ID: 28698342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
